News Releases

Keyword Search

Year None20192018201720162015201420132012

Date	Title
04/02/19	Millendo Therapeutics, Inc. to Present at the 18th Annual Needham Healthcare Conference
03/29/19	Millendo Reports Full Year 2018 Operating and Financial Results
03/19/19	Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
03/14/19	Millendo Therapeutics Announces ENDO 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia
03/04/19	Millendo Therapeutics, Inc. to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference
02/21/19	Millendo Therapeutics, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference
02/01/19	Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/17/19	Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)